Israeli Prime Minister Netanyahu Reveals Treatment for Early-Stage Prostate Cancer After Two-Month Delay
Introduction
Israeli Prime Minister Benjamin Netanyahu has announced that he underwent treatment for early-stage prostate cancer. He acknowledged a two-month delay in sharing this medical information publicly during the ongoing conflict with Iran.
Main Body
According to Netanyahu's annual medical report released on Friday, the tumor was found at a very early stage with no signs of spreading, and the condition has been fully treated. Dr. Aharon Popovtser, head of oncology at Hadassah Hospital, stated that later scans and blood tests showed the disease has resolved. Netanyahu explained that he asked for the information to be kept secret to prevent its release during the most intense period of the war against Iran. He argued that making it public could have been used for what he called false propaganda against Israel. He also noted that his doctors described the condition as minor and common for men his age, giving him the choice of monitoring or immediate treatment. In a social media post, Netanyahu emphasized that when he learns of a potential danger, he prefers to deal with it quickly. He said this is a rule he follows both as a national leader and in his personal life. The 76-year-old leader had previously undergone surgery for an enlarged benign prostate in 2024 and was being regularly checked when the tumor was discovered. The exact date of the cancer treatment is not known. His office reported that the rest of the medical examination showed he is in good overall health. The announcement came after weeks of public guessing about Netanyahu's health. He had missed several security cabinet meetings in a row during the early part of the US-Israel military campaign against Iran. In March, he released a video of himself waving at a café in Jerusalem. This was an attempt to fight rumors that recent videos of his public appearances were made by artificial intelligence.
Conclusion
The disclosure ends a period of uncertainty about the prime minister's physical condition. It confirms a successful treatment outcome but also raises questions about the timing of health-related transparency during a time of national conflict.